Chronic Obstructive Pulmonary Disease-Related Mortality in Brazil, 2000-2019: A Multiple-Cause-of-Death Study

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSANTO, Augusto Hasiak
dc.contributor.authorFERNANDES, Frederico Leon Arrabal
dc.date.accessioned2022-06-20T15:41:21Z
dc.date.available2022-06-20T15:41:21Z
dc.date.issued2022
dc.description.abstractChronic obstructive pulmonary disease (COPD) remains a compelling cause of morbidity and mortality; however, it is underestimated and undertreated in Brazil. Using multiple causes of death data from the Information System on Mortality, we evaluated, from 2000 to 2019, national proportional mortality; trends in mortality rates stratified by age, sex, and macro-region; and causes of death and seasonal variation, considering COPD as an underlying and associated cause of death. COPD occurred in 1,132,968 deaths, corresponding to a proportional mortality of 5.0% (5.2% and 4.7% among men and women), 67.6% as the underlying, and 32.4% as an associated cause of death. The standardized mortality rate decreased by 25.8% from 2000 to 2019, and the underlying, associated, male and female, Southeast, South, and Center-West region deaths revealed decreasing standardized mortality trends. The mean age at death increased from 73.2 (+/- 12.5) to 76.0 (+/- 12.0) years of age. Respiratory diseases were the leading underlying causes, totaling 69.8%, with COPD itself reported for 67.6% of deaths, followed by circulatory diseases (15.8%) and neoplasms (6.24%). Respiratory failure, pneumonia, septicemia, and hypertensive diseases were the major associated causes of death. Significant seasonal variations, with the highest proportional COPD mortality during winter, occurred in the southeast, south, and center-west regions. This study discloses the need and value to accurately document epidemiologic trends related to COPD in Brazil, provided its burden on mortality in older age as a significant cause of death, aiming at effective planning of mortality prevention and control.eng
dc.description.indexMEDLINEeng
dc.identifier.citationCOPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, v.19, n.1, p.216-225, 2022
dc.identifier.doi10.1080/15412555.2022.2061934
dc.identifier.eissn1541-2563
dc.identifier.issn1541-2555
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/47425
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS INCeng
dc.relation.ispartofCopd-Journal of Chronic Obstructive Pulmonary Disease
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright TAYLOR & FRANCIS INCeng
dc.subjectChronic obstructive pulmonary diseaseeng
dc.subjectcause of deatheng
dc.subjectdeath certificateeng
dc.subjectmortalityeng
dc.subject.othercopd mortalityeng
dc.subject.otherunited-stateseng
dc.subject.otherlung-diseaseeng
dc.subject.othertrendseng
dc.subject.othermorbiditieseng
dc.subject.wosMedicine, General & Internaleng
dc.titleChronic Obstructive Pulmonary Disease-Related Mortality in Brazil, 2000-2019: A Multiple-Cause-of-Death Studyeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalSANTO, Augusto Hasiak:Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Rua Para,21 Apt 62, BR-01243020 Sao Paulo, Brazil
hcfmusp.citation.scopus4
hcfmusp.contributor.author-fmusphcFREDERICO LEON ARRABAL FERNANDES
hcfmusp.description.beginpage216
hcfmusp.description.endpage225
hcfmusp.description.issue1
hcfmusp.description.volume19
hcfmusp.origemWOS
hcfmusp.origem.pubmed35416733
hcfmusp.origem.scopus2-s2.0-85128135037
hcfmusp.origem.wosWOS:000783504500001
hcfmusp.publisher.cityPHILADELPHIAeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.reference[Anonymous], 2019, JOINPOINT REGRESSIONeng
hcfmusp.relation.referenceBai JW, 2017, INT J CHRONIC OBSTR, V12, P3323, DOI 10.2147/COPD.S150243eng
hcfmusp.relation.referenceBensenor IM, 2011, INT J TUBERC LUNG D, V15, P399eng
hcfmusp.relation.referenceBrasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2020, VIG BRAS 2019 VIG FAeng
hcfmusp.relation.referenceCampos HS., 2003, PULMAO, V12, P217eng
hcfmusp.relation.referenceCarvalho-Pinto RM, 2019, J BRAS PNEUMOL, V45, DOI 10.1590/1806-3713/e20180355eng
hcfmusp.relation.referenceChakraborti A, 2019, CHEST, V156, p1164A, DOI 10.1016/j.chest.2019.08.1060eng
hcfmusp.relation.referenceCheng Y, 2014, CHINESE MED J-PEKING, V127, P1619, DOI 10.3760/cma.j.issn.0366-6999.20132432eng
hcfmusp.relation.referenceCorrea PRL., 2019, REV BRAS EPIDEMIOL, V22eng
hcfmusp.relation.referenceCruz MM, 2020, CIENC SAUDE COLETIVA, V25, P4547, DOI 10.1590/1413-812320202511.00222019eng
hcfmusp.relation.referencede la Iglesia Martinez F, 2000, Arch Bronconeumol, V36, P84eng
hcfmusp.relation.referenceFernandez-Garcia A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10051117eng
hcfmusp.relation.referenceFuhrman C, 2006, THORAX, V61, P930, DOI 10.1136/thx.2006.061267eng
hcfmusp.relation.referenceFuhrman C, 2010, REV MAL RESPIR, V27, P160, DOI 10.1016/j.rmr.2009.08.003eng
hcfmusp.relation.referenceGoncalves-Macedo L, 2019, J BRAS PNEUMOL, V45, DOI 10.1590/1806-3713/e20180402eng
hcfmusp.relation.referenceGraudenz GS, 2014, REV ASSOC MED BRAS, V60, P255, DOI 10.1590/1806-9282.60.03.015eng
hcfmusp.relation.referenceHansell AL, 2003, EUR RESPIR J, V22, P809, DOI 10.1183/09031936.03.00031403eng
hcfmusp.relation.referenceLi XC, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m234eng
hcfmusp.relation.referenceLindberg A, 2021, RESP MED, V186, DOI 10.1016/j.rmed.2021.106518eng
hcfmusp.relation.referenceLopez, 2001, AGE STANDARDIZATION, V31, P10eng
hcfmusp.relation.referenceLortet-Tieulent J, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01791-2019eng
hcfmusp.relation.referenceMannino DM, 1997, AM J RESP CRIT CARE, V156, P814, DOI 10.1164/ajrccm.156.3.9702026eng
hcfmusp.relation.referenceMarcon A, 2016, COPD, V13, P35, DOI 10.3109/15412555.2015.1043427eng
hcfmusp.relation.referenceMenezes Ana Maria Baptista, 2005, Cad. Saúde Pública, V21, P1565, DOI 10.1590/S0102-311X2005000500030eng
hcfmusp.relation.referenceMeyer PA, 2002, CHEST, V122, P2003, DOI 10.1378/chest.122.6.2003eng
hcfmusp.relation.referenceObi JI, 2018, AM J RESP CRIT CARE, V197eng
hcfmusp.relation.referenceObi J, 2018, COPD, V15, P200, DOI 10.1080/15412555.2018.1454897eng
hcfmusp.relation.referencePatel AR, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.4985eng
hcfmusp.relation.referenceReitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-Xeng
hcfmusp.relation.referenceSanto AH., 2019, 4 INT M MULT CAUS DEeng
hcfmusp.relation.referenceSanto AH, 1988, THESIS U SAO PAULOeng
hcfmusp.relation.referenceSanto AH., 1999, REV BRAS EPIDEMIOL, V2, P90, DOI [10.1590/S1415-790X1999000100009, DOI 10.1590/S1415-790X1999000100009]eng
hcfmusp.relation.referenceSanto AH., 2022, REASE, V8, P1620, DOI [10.51891/rease.v8i1.4008, DOI 10.51891/REASE.V8I1.4008]eng
hcfmusp.relation.referenceSanto Augusto Hasiak, 1995, Boletin de la Oficina Sanitaria Panamericana, V119, P319eng
hcfmusp.relation.referenceSasieta Tello HC., 2014, AM J RESP CRIT CARE, V189eng
hcfmusp.relation.referenceSilva D, 2020, VALUE HEALTH, V23, pS727eng
hcfmusp.relation.referenceWorld Health Organization, 1993, INT STAT CLASS DIS R, V1eng
hcfmusp.relation.referenceWorld Health Organization, 1993, INSTRUCTION MANUAL, V2eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationb3a03368-4346-41fb-8f4e-a63c0c038b48
relation.isAuthorOfPublication.latestForDiscoveryb3a03368-4346-41fb-8f4e-a63c0c038b48
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_SANTO_Chronic_Obstructive_Pulmonary_DiseaseRelated_Mortality_in_Brazil_20002019_2022.PDF
Tamanho:
1.39 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)